1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Lecoq, L.
Omichinski, J.G.
Raiola, L.
Cyr, N.
Chabot, P.
Arseneault, G.
Legault, P.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
UK
Nucleic Acids Res.
NARHAD
0389
1362-4962
45
5564
5576
10.1093/nar/gkx146
28334776
Structural characterization of interactions between transactivation domain 1 of the p65 subunit of NF-kappa B and transcription regulatory factors.
2017
10.2210/pdb5urn/pdb
pdb_00005urn
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
12903.701
RNA polymerase II transcription factor B subunit 1
PLECKSTRIN HOMOLOGY DOMAIN, UNP RESIDUES 2-115
1
man
polymer
The first GS residues come from a purification TAG.
3378.591
Transcription factor p65
TRANSACTIVATION DOMAIN 1, UNP RESIDUES 521-551
L523Y
1
man
polymer
General transcription and DNA repair factor IIH subunit TFB1,TFIIH subunit TFB1,RNA polymerase II transcription factor B 73 kDa subunit,RNA polymerase II transcription factor B p73 subunit
Nuclear factor NF-kappa-B p65 subunit,Nuclear factor of kappa light polypeptide gene enhancer in B-cells 3
no
no
PSHSGAAIFEKVSGIIAINEDVSPAELTWRSTDGDKVHTVVLSTIDKLQATPASSEKMMLRLIGKVDESKKRKDNEGNEV
VPKPQRHMFSFNNRTVMDNIKMTLQQIISRYKDAD
PSHSGAAIFEKVSGIIAINEDVSPAELTWRSTDGDKVHTVVLSTIDKLQATPASSEKMMLRLIGKVDESKKRKDNEGNEV
VPKPQRHMFSFNNRTVMDNIKMTLQQIISRYKDAD
A
polypeptide(L)
no
no
GSPGYPNGLLSGDEDFSSIADMDFSALLSQISS
GSPGYPNGLLSGDEDFSSIADMDFSALLSQISS
B
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
Baker's yeast
ATCC 204508 / S288c
sample
1
115
TFB1, YDR311W, D9740.3
559292
Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
562
Escherichia coli
PGEX-TEV
Biological sequence
Human
sample
1
33
RELA, NFKB3
9606
Homo sapiens
562
Escherichia coli
PGEX-TEV
Biological sequence
database_2
pdbx_database_status
pdbx_nmr_software
repository
Initial release
Derived calculations
Database references
Database references
Data collection
Database references
Other
1
0
2017-03-08
1
1
2017-03-22
1
2
2017-04-05
1
3
2017-05-31
1
4
2023-06-14
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_database_status.status_code_nmr_data
_pdbx_nmr_software.name
2017-03-08
SPRSDE
CHEMICAL SHIFTS OF FREE TFB1
NMR STRUCTURE OF THE PH DOMAIN OF TFB1
NMR STRUCTURE OF TFB1 IN COMPLEX WITH ACTIVATION DOMAIN OF P53
NMR STRUCTURE OF TFB1 IN COMPLEX WITH ACTIVATION DOMAIN OF VP16
NMR STRUCTURE OF TFB1 IN COMPLEX WITH ACTIVATION DOMAIN OF EKLF
NMR STRUCTURE OF TFB1 IN COMPLEX WITH RAD2
NMR STRUCTURE OF TFB1 IN COMPLEX WITH RAD4
NMR structures of the Complex Between the Acidic Transactivation Domain of EBNA2 and the Tfb1 subunit of TFIIH.
NMR structure of the complex between the C-terminal domain of the Rift Valley fever virus protein NSs and the PH domain of the Tfb1 subunit of TFIIH
NMR structure of the complex between the PH domain of the Tfb1 subunit from TFIIH and the transactivation domain 1 of p65
N
RCSB
Y
RCSB
2017-02-11
REL
REL
REL
REL
structures with the lowest energy
260
20
isotropic
1
2D 1H-15N HSQC
isotropic
3
2D 1H-13C HSQC aliphatic
isotropic
3
2D 1H-13C HSQC aromatic
isotropic
1
3D HNCO
isotropic
1
3D HNCACB
isotropic
1
3D HBHA(CO)NH
isotropic
1
3D HCCH-TOCSY
isotropic
1
3D 1H-15N NOESY
isotropic
3
3D 1H-13C NOESY
isotropic
3
3D INTERMOLECULAR NOESY
isotropic
1
3D C(CO)NH
isotropic
1
2D 1H-15N HSQC
isotropic
1
2D 1H-13C HSQC aliphatic
isotropic
1
2D 1H-13C HSQC aromatic
isotropic
1
3D HNCO
isotropic
1
3D HNCACB
isotropic
1
3D 1H-15N NOESY
isotropic
3
3D 1H-13C NOESY
isotropic
3
3D INTERMOLECULAR NOESY
0.8
mM
[U-99% 13C; U-99% 15N]
1.6
mM
natural abundance
0.8
mM
[U-99% 13C; U-99% 15N]
1.6
mM
natural abundance
0.8
mM
[U-99% 13C; U-99% 15N]
1.6
mM
natural abundance
0.8
mM
[U-99% 13C; U-99% 15N]
1.6
mM
natural abundance
0
mM
Condition1
6.5
pH
AMBIENT
298
K
SIDECHAINS OPTIMIZATION WITH YASARA
simulated annealing
1
0.8 mM [U-99% 13C; U-99% 15N] RNA POLYMERASE II TRANSCRIPTION FACTOR B SUBUNIT 1, 1.6 mM TRANSCRIPTION FACTOR P65, 90% H2O/10% D2O
13C-15N labeled Tfb1 with 2 equivalents of unlabeled p65-TA1.
Tfb1-p65
90% H2O/10% D2O
solution
0.8 mM [U-99% 13C; U-99% 15N] RNA POLYMERASE II TRANSCRIPTION FACTOR B SUBUNIT 1, 1.6 mM TRANSCRIPTION FACTOR P65, 100% D2O
13C-15N labeled Tfb1 with 2 equivalents of unlabeled p65-TA1 in D20.
Tfb1-p65-D2O
100% D2O
solution
0.8 mM [U-99% 13C; U-99% 15N] TRANSCRIPTION FACTOR P65, 1.6 mM RNA POLYMERASE II TRANSCRIPTION FACTOR B SUBUNIT 1, 90% H2O/10% D2O
13C-15N labeled p65-TA1 with 2 equivalents of unlabeled Tfb1.
p65-Tfb1
90% H2O/10% D2O
solution
0.8 mM [U-99% 13C; U-99% 15N] TRANSCRIPTION FACTOR P65, 1.6 mM RNA POLYMERASE II TRANSCRIPTION FACTOR B SUBUNIT 1, 100% D2O
13C-15N labeled p65-TA1 with 2 equivalents of unlabeled Tfb1 in D2O.
p65-Tfb1-D2O
100% D2O
solution
BRUNGER A. T. ET.AL.
refinement
CNS
KRIEGER ET AL
refinement
YASARA
structure solution
ARIA
structure solution
CCPNMR
structure solution
VNMR
structure solution
NMRPipe
600
Varian
INOVA
800
Varian
INOVA
PRO
1
n
1
PRO
1
A
SER
2
n
2
SER
2
A
HIS
3
n
3
HIS
3
A
SER
4
n
4
SER
4
A
GLY
5
n
5
GLY
5
A
ALA
6
n
6
ALA
6
A
ALA
7
n
7
ALA
7
A
ILE
8
n
8
ILE
8
A
PHE
9
n
9
PHE
9
A
GLU
10
n
10
GLU
10
A
LYS
11
n
11
LYS
11
A
VAL
12
n
12
VAL
12
A
SER
13
n
13
SER
13
A
GLY
14
n
14
GLY
14
A
ILE
15
n
15
ILE
15
A
ILE
16
n
16
ILE
16
A
ALA
17
n
17
ALA
17
A
ILE
18
n
18
ILE
18
A
ASN
19
n
19
ASN
19
A
GLU
20
n
20
GLU
20
A
ASP
21
n
21
ASP
21
A
VAL
22
n
22
VAL
22
A
SER
23
n
23
SER
23
A
PRO
24
n
24
PRO
24
A
ALA
25
n
25
ALA
25
A
GLU
26
n
26
GLU
26
A
LEU
27
n
27
LEU
27
A
THR
28
n
28
THR
28
A
TRP
29
n
29
TRP
29
A
ARG
30
n
30
ARG
30
A
SER
31
n
31
SER
31
A
THR
32
n
32
THR
32
A
ASP
33
n
33
ASP
33
A
GLY
34
n
34
GLY
34
A
ASP
35
n
35
ASP
35
A
LYS
36
n
36
LYS
36
A
VAL
37
n
37
VAL
37
A
HIS
38
n
38
HIS
38
A
THR
39
n
39
THR
39
A
VAL
40
n
40
VAL
40
A
VAL
41
n
41
VAL
41
A
LEU
42
n
42
LEU
42
A
SER
43
n
43
SER
43
A
THR
44
n
44
THR
44
A
ILE
45
n
45
ILE
45
A
ASP
46
n
46
ASP
46
A
LYS
47
n
47
LYS
47
A
LEU
48
n
48
LEU
48
A
GLN
49
n
49
GLN
49
A
ALA
50
n
50
ALA
50
A
THR
51
n
51
THR
51
A
PRO
52
n
52
PRO
52
A
ALA
53
n
53
ALA
53
A
SER
54
n
54
SER
54
A
SER
55
n
55
SER
55
A
GLU
56
n
56
GLU
56
A
LYS
57
n
57
LYS
57
A
MET
58
n
58
MET
58
A
MET
59
n
59
MET
59
A
LEU
60
n
60
LEU
60
A
ARG
61
n
61
ARG
61
A
LEU
62
n
62
LEU
62
A
ILE
63
n
63
ILE
63
A
GLY
64
n
64
GLY
64
A
LYS
65
n
65
LYS
65
A
VAL
66
n
66
VAL
66
A
ASP
67
n
67
ASP
67
A
GLU
68
n
68
GLU
68
A
SER
69
n
69
SER
69
A
LYS
70
n
70
LYS
70
A
LYS
71
n
71
LYS
71
A
ARG
72
n
72
ARG
72
A
LYS
73
n
73
LYS
73
A
ASP
74
n
74
ASP
74
A
ASN
75
n
75
ASN
75
A
GLU
76
n
76
GLU
76
A
GLY
77
n
77
GLY
77
A
ASN
78
n
78
ASN
78
A
GLU
79
n
79
GLU
79
A
VAL
80
n
80
VAL
80
A
VAL
81
n
81
VAL
81
A
PRO
82
n
82
PRO
82
A
LYS
83
n
83
LYS
83
A
PRO
84
n
84
PRO
84
A
GLN
85
n
85
GLN
85
A
ARG
86
n
86
ARG
86
A
HIS
87
n
87
HIS
87
A
MET
88
n
88
MET
88
A
PHE
89
n
89
PHE
89
A
SER
90
n
90
SER
90
A
PHE
91
n
91
PHE
91
A
ASN
92
n
92
ASN
92
A
ASN
93
n
93
ASN
93
A
ARG
94
n
94
ARG
94
A
THR
95
n
95
THR
95
A
VAL
96
n
96
VAL
96
A
MET
97
n
97
MET
97
A
ASP
98
n
98
ASP
98
A
ASN
99
n
99
ASN
99
A
ILE
100
n
100
ILE
100
A
LYS
101
n
101
LYS
101
A
MET
102
n
102
MET
102
A
THR
103
n
103
THR
103
A
LEU
104
n
104
LEU
104
A
GLN
105
n
105
GLN
105
A
GLN
106
n
106
GLN
106
A
ILE
107
n
107
ILE
107
A
ILE
108
n
108
ILE
108
A
SER
109
n
109
SER
109
A
ARG
110
n
110
ARG
110
A
TYR
111
n
111
TYR
111
A
LYS
112
n
112
LYS
112
A
ASP
113
n
113
ASP
113
A
ALA
114
n
114
ALA
114
A
ASP
115
n
115
ASP
115
A
GLY
519
n
1
GLY
519
B
SER
520
n
2
SER
520
B
PRO
521
n
3
PRO
521
B
GLY
522
n
4
GLY
522
B
TYR
523
n
5
TYR
523
B
PRO
524
n
6
PRO
524
B
ASN
525
n
7
ASN
525
B
GLY
526
n
8
GLY
526
B
LEU
527
n
9
LEU
527
B
LEU
528
n
10
LEU
528
B
SER
529
n
11
SER
529
B
GLY
530
n
12
GLY
530
B
ASP
531
n
13
ASP
531
B
GLU
532
n
14
GLU
532
B
ASP
533
n
15
ASP
533
B
PHE
534
n
16
PHE
534
B
SER
535
n
17
SER
535
B
SER
536
n
18
SER
536
B
ILE
537
n
19
ILE
537
B
ALA
538
n
20
ALA
538
B
ASP
539
n
21
ASP
539
B
MET
540
n
22
MET
540
B
ASP
541
n
23
ASP
541
B
PHE
542
n
24
PHE
542
B
SER
543
n
25
SER
543
B
ALA
544
n
26
ALA
544
B
LEU
545
n
27
LEU
545
B
LEU
546
n
28
LEU
546
B
SER
547
n
29
SER
547
B
GLN
548
n
30
GLN
548
B
ILE
549
n
31
ILE
549
B
SER
550
n
32
SER
550
B
SER
551
n
33
SER
551
B
author_and_software_defined_assembly
PISA
2
dimeric
980
-6
10330
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
identity operation
0.0000000000
0.0000000000
0.0000000000
A
N
ALA
7
A
N
ALA
7
A
O
GLY
14
A
O
GLY
14
A
N
ALA
17
A
N
ALA
17
A
O
THR
28
A
O
THR
28
A
N
LEU
27
A
N
LEU
27
A
O
VAL
40
A
O
VAL
40
A
N
GLN
49
A
N
GLN
49
A
O
ARG
61
A
O
ARG
61
A
N
LEU
62
A
N
LEU
62
A
O
HIS
87
A
O
HIS
87
A
N
ARG
72
A
N
ARG
72
A
O
VAL
80
A
O
VAL
80
1
A
A
HG
H
SER
GLY
31
34
1.28
1
A
A
H
O
LEU
VAL
27
40
1.54
1
A
A
O
H
GLN
ARG
49
61
1.57
2
A
A
OD1
HG
ASP
SER
67
69
1.57
2
A
A
HG
OD1
SER
ASP
31
35
1.59
3
A
A
HG
H
SER
LYS
55
57
1.26
4
A
B
HG
HE22
SER
GLN
54
548
1.30
5
A
A
HG
OD1
SER
ASP
31
35
1.56
6
A
A
HD2
HG1
HIS
THR
3
103
1.33
7
A
A
O
HG1
VAL
THR
41
44
1.52
7
A
A
HG
OD1
SER
ASP
31
35
1.53
8
A
A
HG
H
SER
LYS
31
36
1.32
8
A
A
HB3
HD2
ALA
ARG
53
94
1.33
8
A
A
H
O
LEU
VAL
27
40
1.51
9
B
B
HG
HB2
SER
GLU
529
532
1.21
9
A
A
HG
H
SER
LYS
31
36
1.34
10
A
A
HG
H
SER
LYS
31
36
1.34
10
A
A
O
H
LEU
HIS
62
87
1.60
11
A
A
CB
OE2
ASP
GLU
74
76
2.10
12
A
A
HG23
HZ2
VAL
LYS
12
36
1.13
13
A
B
HG
HE22
SER
GLN
54
548
1.26
13
A
A
O
HG1
VAL
THR
41
44
1.49
13
A
A
HG
OD1
SER
ASP
31
35
1.51
14
A
A
HG
H
SER
LYS
31
36
1.33
15
A
A
HG
H
SER
LYS
31
36
1.29
17
A
A
H
O
LEU
VAL
27
40
1.52
17
A
A
HG
OD1
SER
ASP
31
35
1.59
18
A
A
HD2
HG1
HIS
THR
3
103
1.27
19
A
A
HG
H
SER
GLY
31
34
1.34
1
A
A
SER
PRO
23
24
-140.01
2
A
A
SER
PRO
23
24
-139.40
3
A
A
SER
PRO
23
24
-142.21
4
A
A
SER
PRO
23
24
-139.53
5
A
A
SER
PRO
23
24
-142.71
6
A
A
SER
PRO
23
24
-139.42
7
A
A
SER
PRO
23
24
-139.00
8
A
A
SER
PRO
23
24
-140.12
9
A
A
SER
PRO
23
24
-142.16
10
A
A
SER
PRO
23
24
-139.41
11
A
A
SER
PRO
23
24
-139.71
12
A
A
SER
PRO
23
24
-140.28
13
A
A
SER
PRO
23
24
-143.48
14
A
A
SER
PRO
23
24
-143.19
15
A
A
SER
PRO
23
24
-142.86
16
A
A
SER
PRO
23
24
-141.44
17
A
A
SER
PRO
23
24
-141.45
18
A
A
SER
PRO
23
24
-141.62
19
A
A
SER
PRO
23
24
-139.40
20
A
A
SER
PRO
23
24
-139.56
1
A
A
CG
CD
PRO
PRO
1
1
0.202
0.027
1.512
1.714
N
2
B
B
CE1
CZ
PHE
PHE
542
542
0.152
0.019
1.369
1.521
N
2
B
B
CZ
CE2
PHE
PHE
542
542
-0.136
0.019
1.369
1.233
N
4
A
A
CG
CD
PRO
PRO
1
1
0.195
0.027
1.512
1.707
N
5
A
A
CG
CD
PRO
PRO
1
1
0.259
0.027
1.512
1.771
N
5
B
B
CE1
CZ
PHE
PHE
542
542
0.140
0.019
1.369
1.509
N
5
B
B
CZ
CE2
PHE
PHE
542
542
-0.125
0.019
1.369
1.244
N
6
A
A
CG
CD
PRO
PRO
1
1
0.175
0.027
1.512
1.687
N
7
A
A
CG
CD
PRO
PRO
1
1
0.213
0.027
1.512
1.725
N
8
A
A
CG
CD
PRO
PRO
1
1
0.226
0.027
1.512
1.738
N
9
B
B
CE1
CZ
PHE
PHE
542
542
0.124
0.019
1.369
1.493
N
11
A
A
CG
CD
PRO
PRO
1
1
0.250
0.027
1.512
1.762
N
11
B
B
CE1
CZ
PHE
PHE
542
542
0.141
0.019
1.369
1.510
N
11
B
B
CZ
CE2
PHE
PHE
542
542
-0.125
0.019
1.369
1.244
N
14
A
A
CG
CD
PRO
PRO
1
1
0.187
0.027
1.512
1.699
N
16
A
A
CG
CD
PRO
PRO
1
1
0.186
0.027
1.512
1.698
N
20
B
B
CE1
CZ
PHE
PHE
542
542
0.141
0.019
1.369
1.510
N
20
B
B
CZ
CE2
PHE
PHE
542
542
-0.123
0.019
1.369
1.246
N
1
A
HIS
3
70.71
-31.53
1
A
LYS
11
70.61
-6.35
1
A
LYS
70
-97.19
34.51
1
A
ALA
114
53.76
86.69
1
B
SER
529
-149.16
-71.16
1
B
ASP
531
-152.80
-26.60
1
B
GLN
548
53.60
99.87
2
A
LYS
11
70.23
-8.30
2
B
SER
520
61.60
120.05
2
B
SER
550
61.89
129.91
3
A
HIS
3
77.16
-48.83
3
A
LYS
11
70.85
-3.01
3
B
SER
550
55.66
110.09
4
A
LYS
11
55.56
3.47
4
A
LYS
70
-92.20
34.36
4
A
ALA
114
54.64
88.84
4
B
ASN
525
65.08
165.62
4
B
SER
529
-165.53
-53.86
4
B
GLN
548
53.18
100.03
4
B
SER
550
68.67
-58.13
5
A
HIS
3
69.78
-31.66
5
A
LYS
11
70.07
-5.96
5
A
LYS
70
-95.57
36.10
5
A
ALA
114
54.18
87.40
5
B
SER
520
53.78
111.08
5
B
GLN
548
48.34
95.26
6
A
LYS
11
68.72
-5.55
6
A
LYS
70
-96.70
40.49
6
A
ALA
114
54.53
88.06
6
B
TYR
523
57.07
92.25
6
B
GLN
548
53.41
101.77
7
A
HIS
3
69.65
-31.24
7
A
LYS
11
68.22
-5.42
7
A
LYS
70
-84.11
35.01
7
B
TYR
523
57.00
93.93
7
B
SER
547
-111.27
69.80
8
A
LYS
11
69.24
-3.98
8
A
LYS
70
-94.50
37.67
8
B
GLN
548
54.33
101.26
8
B
ILE
549
-104.28
-61.32
8
B
SER
550
58.24
114.82
9
A
LYS
11
69.49
-6.18
9
A
ALA
114
54.02
87.66
9
B
TYR
523
58.07
80.78
9
B
ASN
525
42.70
86.54
9
B
SER
529
-162.22
-42.97
9
B
SER
547
-95.04
39.65
10
A
SER
2
60.16
165.12
10
A
HIS
3
74.07
-53.06
10
A
LYS
11
69.84
-5.15
10
A
LYS
70
-91.98
33.54
10
B
SER
529
66.64
60.28
11
A
LYS
11
68.66
-2.31
11
B
SER
529
-134.88
-36.26
11
B
GLN
548
-112.73
76.30
12
A
LYS
11
70.67
-8.49
12
A
ALA
114
54.70
89.33
12
B
TYR
523
57.13
85.19
12
B
GLN
548
50.10
98.04
13
A
HIS
3
69.54
-26.54
13
A
LYS
11
71.57
-7.00
13
A
ALA
114
53.84
87.40
13
B
SER
520
59.45
101.15
13
B
SER
529
-155.85
-49.93
13
B
GLN
548
52.32
100.41
14
A
HIS
3
67.43
-18.20
14
A
LYS
11
69.28
-7.46
14
A
LYS
70
-97.05
37.98
14
B
TYR
523
59.14
88.64
14
B
LEU
527
60.69
113.64
14
B
SER
529
-154.68
-63.73
14
B
SER
547
-106.76
42.70
15
A
LYS
11
70.17
-7.42
15
A
LYS
70
-99.94
33.19
15
A
ALA
114
52.36
83.22
15
B
SER
529
-151.58
63.12
15
B
GLN
548
51.21
93.15
15
B
ILE
549
58.11
78.32
15
B
SER
550
61.08
-73.45
16
A
HIS
3
67.52
-29.73
16
A
LYS
11
70.84
-8.42
16
A
ALA
114
54.59
88.67
16
B
ASN
525
62.94
116.55
16
B
SER
529
-144.38
-53.62
16
B
SER
547
-99.42
42.87
17
A
LYS
11
69.64
-6.76
17
A
ALA
114
55.88
89.64
17
B
SER
520
62.01
121.63
17
B
LEU
527
58.32
107.89
17
B
SER
529
-155.61
42.26
17
B
SER
547
-106.22
58.83
18
A
LYS
11
69.26
-5.27
18
A
LYS
70
-96.14
39.67
18
B
GLN
548
52.18
100.52
19
A
LYS
11
70.67
-7.54
19
A
LYS
70
-87.42
33.64
19
B
TYR
523
57.76
92.94
19
B
LEU
528
62.43
-15.13
19
B
SER
529
-141.28
-58.13
19
B
GLN
548
50.33
97.30
20
A
LYS
11
69.21
-4.68
20
A
ALA
114
53.00
85.08
20
B
GLN
548
-102.26
71.67
N
NMR structure of the complex between the PH domain of the Tfb1 subunit from TFIIH and the transactivation domain 1 of p65
1
N
N
2
N
N
A
ASN
93
A
ASN
93
HELX_P
A
ALA
114
A
ALA
114
1
AA1
22
B
PHE
534
B
PHE
16
HELX_P
B
LEU
546
B
LEU
28
1
AA2
13
TRANSCRIPTION
TRANSCRIPTION FACTOR TFIIH, TRANSACTIVATION DOMAIN, NUCLEAR FACTOR KAPPA-B, TRANSCRIPTIONAL ACTIVATION, P62/TFB1 SUBUNIT, TRANSCRIPTION
TFB1_YEAST
UNP
1
2
P32776
SHSGAAIFEKVSGIIAINEDVSPAELTWRSTDGDKVHTVVLSTIDKLQATPASSEKMMLRLIGKVDESKKRKDNEGNEVV
PKPQRHMFSFNNRTVMDNIKMTLQQIISRYKDAD
TF65_HUMAN
UNP
2
521
Q04206
PGLPNGLLSGDEDFSSIADMDFSALLSQISS
2
115
5URN
2
115
P32776
A
1
2
115
521
551
5URN
521
551
Q04206
B
2
3
33
1
expression tag
PRO
1
5URN
A
P32776
UNP
1
2
expression tag
GLY
519
5URN
B
Q04206
UNP
1
2
expression tag
SER
520
5URN
B
Q04206
UNP
2
2
LEU
engineered mutation
TYR
523
5URN
B
Q04206
UNP
523
5
4
3
2
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
A
ALA
7
A
ALA
7
A
PHE
9
A
PHE
9
A
VAL
12
A
VAL
12
A
ASN
19
A
ASN
19
A
GLU
26
A
GLU
26
A
SER
31
A
SER
31
A
VAL
37
A
VAL
37
A
VAL
41
A
VAL
41
A
ILE
45
A
ILE
45
A
ALA
50
A
ALA
50
A
MET
59
A
MET
59
A
GLY
64
A
GLY
64
A
ARG
86
A
ARG
86
A
SER
90
A
SER
90
A
ARG
72
A
ARG
72
A
LYS
73
A
LYS
73
A
GLU
79
A
GLU
79
A
VAL
80
A
VAL
80
1
P 1